122 related articles for article (PubMed ID: 22452647)
1. Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature.
Iacovelli R; Altavilla A; Ciardi A; Urbano F; Manai C; Gentile V; Cortesi E
BJU Int; 2012 Nov; 110(10):1449-54. PubMed ID: 22452647
[TBL] [Abstract][Full Text] [Related]
2. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney.
Risi E; Iacovelli R; Altavilla A; Alesini D; Palazzo A; Mosillo C; Trenta P; Cortesi E
Urology; 2013 Aug; 82(2):382-6. PubMed ID: 23800653
[TBL] [Abstract][Full Text] [Related]
4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
5. Primary synovial sarcoma of the kidney with rhabdoid features.
Paláu L MA; Thu Pham T; Barnard N; Merino MJ
Int J Surg Pathol; 2007 Oct; 15(4):421-8. PubMed ID: 17913954
[TBL] [Abstract][Full Text] [Related]
6. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
[TBL] [Abstract][Full Text] [Related]
7. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
[TBL] [Abstract][Full Text] [Related]
8. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
9. [Primitive renal synovial sarcoma: a cystic tumor in young patients].
Long JA; Dinia EM; Saada-Sebag G; Cyprien J; Pasquier D; Thuillier C; Terrier N; Boillot B; Descotes JL; Rambeaud JJ
Prog Urol; 2009 Jul; 19(7):474-8. PubMed ID: 19559377
[TBL] [Abstract][Full Text] [Related]
10. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
12. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
13. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
[TBL] [Abstract][Full Text] [Related]
14. Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.
Seidel C; Busch J; Weikert S; Steffens S; Fenner M; Ganser A; Grünwald V
Eur J Cancer; 2012 May; 48(7):1023-30. PubMed ID: 22436979
[TBL] [Abstract][Full Text] [Related]
15. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML
Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687
[TBL] [Abstract][Full Text] [Related]
16. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome.
Okcu MF; Munsell M; Treuner J; Mattke A; Pappo A; Cain A; Ferrari A; Casanova M; Ozkan A; Raney B
J Clin Oncol; 2003 Apr; 21(8):1602-11. PubMed ID: 12697886
[TBL] [Abstract][Full Text] [Related]
17. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal synovial sarcoma: a clinicopathological study of 6 cases.
Chatzipantelis P; Kafiri G
J BUON; 2008; 13(2):211-6. PubMed ID: 18555467
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression is not associated with clinical outcome in synovial sarcoma.
Carmody Soni EE; Miller BJ; Scarborough MT; Reith J; Gibbs CP
Oncol Rep; 2011 Dec; 26(6):1513-7. PubMed ID: 21874258
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
